These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12113828)

  • 21. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
    Emoto N; Raharjo SB; Isaka D; Masuda S; Adiarto S; Jeng AY; Yokoyama M
    Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
    J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin-converting enzyme inhibitors: current status and perspectives.
    Löffler BM
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S79-82. PubMed ID: 10976788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1.
    Firooznia F; Gude C; Chan K; Tan J; Fink CA; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3059-62. PubMed ID: 12372501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-90063, a novel endothelin converting enzyme inhibitor isolated from a new marine bacterium, Blastobacter sp. SANK 71894.
    Takaishi S; Tuchiya N; Sato A; Negishi T; Takamatsu Y; Matsushita Y; Watanabe T; Iijima Y; Haruyama H; Kinoshita T; Tanaka M; Kodama K
    J Antibiot (Tokyo); 1998 Sep; 51(9):805-15. PubMed ID: 9820230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells.
    Berger Y; Dehmlow H; Blum-Kaelin D; Kitas EA; Löffler BM; Aebi JD; Juillerat-Jeanneret L
    J Med Chem; 2005 Jan; 48(2):483-98. PubMed ID: 15658862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of metallopeptidases by flavonoids and related compounds.
    Bormann H; Melzig MF
    Pharmazie; 2000 Feb; 55(2):129-32. PubMed ID: 10723772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV; Sansom CE; Turner AJ
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action.
    De Lombaert S; Blanchard L; Stamford LB; Tan J; Wallace EM; Satoh Y; Fitt J; Hoyer D; Simonsbergen D; Moliterni J; Marcopoulos N; Savage P; Chou M; Trapani AJ; Jeng AY
    J Med Chem; 2000 Feb; 43(3):488-504. PubMed ID: 10669576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives.
    Roques BP
    Pathol Biol (Paris); 1998 Mar; 46(3):191-200. PubMed ID: 9769915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
    Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ
    Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE).
    Melzig MF; Pieper S; Siems WE; Heder G; Bóttger A; Liberra K; Lindequist U
    Pharmazie; 1996 Jul; 51(7):501-3. PubMed ID: 8774843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of triazole-Tethered pyrrolidine libraries: novel ECE inhibitors.
    Kitas EA; Löffler BM; Daetwyler S; Dehmlow H; Aebi JD
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1727-30. PubMed ID: 12067547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CGS 34043: a non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
    Trapani AJ; De Lombaert S; Beil ME; Bruseo CW; Savage P; Chou M; Jeng AY
    Life Sci; 2000; 67(9):1025-33. PubMed ID: 10954036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung.
    Shiosaki K; Tasker AS; Sullivan GM; Sorensen BK; von Geldern TW; Wu-Wong JR; Marselle CA; Opgenorth TJ
    J Med Chem; 1993 Feb; 36(4):468-78. PubMed ID: 8474103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors.
    Firooznia F; Gude C; Chan K; Fink CA; Qiao Y; Satoh Y; Marcopoulos N; Savage P; Beil ME; Bruseo CW; Trapani AJ; Jeng AY
    Bioorg Med Chem Lett; 2001 Feb; 11(3):375-8. PubMed ID: 11212114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.